Growth Metrics

Pfizer (PFE) Pension (2016 - 2026)

Pfizer has reported Pension over the past 18 years, most recently at $2.0 billion for Q1 2026.

  • Quarterly Pension fell 1.83% to $2.0 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $2.0 billion through Mar 2026, down 1.83% year-over-year, with the annual reading at $2.0 billion for FY2025, 3.5% down from the prior year.
  • Pension was $2.0 billion for Q1 2026 at Pfizer, down from $2.0 billion in the prior quarter.
  • Over five years, Pension peaked at $3.3 billion in Q2 2022 and troughed at $2.0 billion in Q1 2026.
  • The 5-year median for Pension is $2.2 billion (2025), against an average of $2.3 billion.
  • The largest YoY upside for Pension was 336.68% in 2022 against a maximum downside of 39.58% in 2022.
  • A 5-year view of Pension shows it stood at $2.2 billion in 2022, then dropped by 3.69% to $2.2 billion in 2023, then fell by 2.4% to $2.1 billion in 2024, then decreased by 3.5% to $2.0 billion in 2025, then decreased by 2.79% to $2.0 billion in 2026.
  • Per Business Quant, the three most recent readings for PFE's Pension are $2.0 billion (Q1 2026), $2.0 billion (Q4 2025), and $2.2 billion (Q3 2025).